These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6972966)

  • 1. Quantitative appraisal of H-2 products in T cell-mediated lysis by allogeneic and syngeneic effector cells.
    Kuppers RC; Ballas ZK; Green WR; Henney CS
    J Immunol; 1981 Aug; 127(2):500-4. PubMed ID: 6972966
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 4. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mapping of an H-2-associated antigen expressed on regulatory T cells.
    Plate JM
    J Immunol; 1980 Jul; 125(1):288-92. PubMed ID: 6966654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in expression of MHC products between several H-2-restricted CTL clones.
    Hauptfeld V; Braciale TJ; Shreffler DC
    J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. I. Effector cells can recognize two distinct classes of hapten-reactive self sites on cell surface proteins.
    Levy RB; Shearer GM; Richardson JC; Henkart PA
    J Immunol; 1981 Aug; 127(2):523-8. PubMed ID: 6972967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated lympholysis responses against autologous cells modified with haptenic sulfhydryl reagents. II. Analysis of the genetic control and H-2-restricted pattern of cytotoxic responses to sulfhydryl and amino reactive reagents.
    Levy RB; Henkart PA; Shearer GM
    J Immunol; 1981 Aug; 127(2):529-34. PubMed ID: 6972968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
    Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
    J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of allosensitized memory lymphocytes into secondary cytotoxic T lymphocytes by third-party stimulator cells: genetic mapping of the stimulating antigens.
    Fan J; Bonavida B
    Transplant Proc; 1981 Dec; 13(4):1897-900. PubMed ID: 7330974
    [No Abstract]   [Full Text] [Related]  

  • 14. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK; Cheng Q; Hui KM
    Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of effector T lymphocytes by initiator T lymphocytes: application for specific immunosuppression.
    Cohen IR; Belldegrün A; Ben-Nun A; Hazan R
    Transplant Proc; 1981 Mar; 13(1 Pt 1):623-5. PubMed ID: 7022903
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of I region gene products in macrophage induction of an antibody response. I. Ability of anti-I-J region sera to block macrophage function.
    Niederhuber JE; Allen P
    J Immunol; 1980 Aug; 125(2):799-806. PubMed ID: 6967090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.